Damage to the musculoskeletal system during eradication therapy of Helicobacter pylori with levofloxacin
https://doi.org/10.31146/1682-8658-ecg-193-9-114-118
Abstract
Eradication therapy is the mainstay of treatment for H. pylori-associated diseases. A case of the development of tendinitis of the left patellar ligament proper during eradication therapy using a triple regimen with levofoloxacin for 14 days for exacerbation of duodenal ulcer is presented.
About the Authors
I. N. Kupriyanova
Federal State Budgetary Educational Institution of Higher Education “Ural State Medical University” of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Inessa N. Kupriyanova - Department of Faculty Therapy, Endocrinology, Allergology and Immunology, Associate Professor, Candidate of Medical Sciences
V. A. Vedensky
Moscow State University M.V. Lomonosov
Russian Federation
Russian Federation
Vsevolod A. Vedensky - Faculty of Fundamental Medicine, student.
19991, Kolmogorova st., 1, Moscow
E. Ya. Valieva
Federal State Budgetary Educational Institution of Higher Education Ural State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Elina Ya. Valieva - medical and preventive faculty, student
M. A. Sinitsina
Federal State Budgetary Educational Institution of Higher Education Ural State Medical University of the Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Marina A. Sinitsina - medical and preventive faculty, student
References
1. Ivashkin V. T., Maev I. V., Lapina T. L., Sheptulin A. A., et al. Helicobacter pylori infection treatment: mainstream and novations. Russian journal of gastroenterology, hepatology and coloproctology. 2017; 27(4): pp 4-21 (in Russ.) doi: 10.22416/1382-4376-2017-27-4-4-21.
2. Ivashkin V. T., Maev I. V., Lapina T. L., Sheptulin A. A., et al. Helicobacter pyloriinfection treatment: mainstream and novations. Russian journal of gastroenterology, hepatology and coloproctology. 2018; 28(1): pp 55-70 (in Russ.). doi: 10.22416/1382-4376-2018-28-1-55-70.
3. Perri F., Festa V., Clemente R., et al. Randomized study of two “rescue” therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Am J Gastroenterol. 2001 Jan;96(1):58-62. doi: 10.1111/j.1572-0241.2001.03452.x.
4. Durey A., Baek Y. S., Park J. S. et al.Levofloxacin-Induced Achilles Tendinitis in a Young Adult in the Absence of Predisposing Conditions. Yonsei Medical Journal. 2010; 51(3):454. doi: 10.3349/ymj.2010.51.3.454.
5. О`Connor A.J.P., O`Morain C.A., Ford A. C. Population screening and treatment of Helicobacter pylori infection. Nature reviews. Gastroenterology and Hepatology. 2017; 14: 230-240. doi: 10.1038/nrgastro.2016.195.
6. Dyadyk A. I., Kugler T. E. Cardiovascular, renal and neuropsychical side effects of Helicobacter pylori eradication therapy. Lechaschiy vrach. 2017; 13:36. (in Russ.)
7. Conforti A., Chiamulera C., Moretti U., et al. Musculoskeletal Adverse Drug Reactions: A Review of Literature and Data from ADR Spontaneous Reporting Databases. Curr DrugSaf. 2007; 2(1):47-63. doi: 10.2174/157488607779315516.
8. Lewis T, Cook J. Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature. J Athlet Train. 2014; 49: 422-427. doi: 10.4085/1062-6050-49.2.09.
9. Simona D. C., Lucia F., Yayha D., et al. Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line. World J Gastroenterol. 2012; 18(40): 5669-5678. doi: 10.3748/wjg.v18.i40.5669.
10. Stasiek M., Głuszko P., Acute Achilles tendon rupture after treatment with levofloxacin in a patient with giant cell arteritis. Reumatologia. 2019; 57(6): 343-346. doi: 10.5114/reum.2019.91277.
11. Ladrón-de-Guevara L., Bornstein-Quevedo L., González-Huezo S. et al. Helicobacter pylori eradication in Mexico with a levofloxacin-based scheme versus standard triple therapy: Results from an open-label, randomized, noninferiority phase iiib trial. Rev Gastroenterol Mex. 2019; 84(3): 274-283. doi: 10.1016/j.rgmx.2018.04.005.
12. Bailey R. R., Kirk J. A., Peddie B. A.Norfloxacin-induced rheumatoid disease. N Z Med J. 1983 Jul 27;96(736):590. PMID: 6223241.
13. Bidell M. R., Lodise T. P. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk? Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2016; 36(6): 679-693.doi: 10.1002/phar.1761.
14. Hall M. M., Finnoff J. T., Smith J. Musculoskeletal Complications of Fluoroquinolones: Guidelines and Precautions for Usage in the Athletic Population. PM R. 2011; 3(2): 132-42. doi: 10.1016/j.pmrj.2010.10.003.
15. Khaliq Y., Zhanel G. G. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003; 36: 1404-1410. doi: 10.1086/375078.
16. Connelly S., Bayliff C., Mehta S. Levofloxacin-induced bilateral Achilles tendinopathy. Canad J Hosp Pharm. 2002; 55: 212-214.
17. Lado Lado F. L., Rodríguez M. C., Velasco G. M., et al. Roturaparcial bilateral aquíleaasociada a levofloxacino. An Med Interna (Madrid). 2005; 22: 28-30. doi: 10.4321/s0212-71992005000100007.
18. Bisaccia, D. R., Aicale, R., Tarantino, D., et al. Biological and chemical changes in fluoroquinolone-associated tendinopathies: a systematic review. British Medical Bulletin. 2019; 130(1): 39-49. doi: 10.1093/bmb/ldz006.
19. Fox A. J.S., Schär M. O., Wanivenhaus F., et al. Fluoroquinolones impair tendon healing in a rat rotator cuff repair model: a preliminary study. Am J Sports Med. 2014; 42: 2851-9. doi: 10.1177/0363546514545858.
20. Kjaer M., Langberg H., Magnusson P. Overuse injuries in tendon tissue: insight into adaptation mechanisms. UgeskrLaeger. 2003; 165: 1438-1443.
21. Fredberg U., Bolvig L. Significance of ultrasonographically detected asymptomatic tendinosis in the patellar and achilles tendons of elite soccer players: a longitudinal study. Am J Sports Med. 2002; 30: 488-491. doi: 10.1177/0363546514545858.
22. Kaleagasioglu F., Olcay E. Fluoroquinolone-induced tendinopathy: etiology and preventive measures. Tohoku J Exp Med. 2012; 226: 251-8. doi:10.1620/tjem.226.251.
23. Petersen W., Pufe T., Zantop T., et al. Hypoxia and PDGF have a synergistic effect that increases the expression of the angiogenetic peptide vascular endothelial growth factor in Achilles tendon fibroblasts. Arch Orthop Trauma Surg. 2003; 123: 485-488. doi: 10.1007/s00402-003-0493-0.
24. Pufe T., Petersen W. J., Mentlein R., Tillmann B. N. The role of vasculature and angiogenesis for the pathogenesis of degenerative tendons disease. Scand J Med Sci Sports. 2005; 15: 211-222. doi: 10.1111/j.1600-0838.2005.00465.x.
25. Tsai W-C, Yang Y-M. Fluoroquinolone-associated tendinopathy. Chang Gung Med J. 2011 Sep-Oct;34(5):461-7. PMID: 22035890.
26. Stahlmann R., Kuhner S., Shakibaei M. et al. Effects of magnesium deficiency on joint cartilage in immature beagle dogs: immunohistochemistry, electron microscopy, and mineral concentrations. Arch Toxicol. 2000; 73: 573-80. doi: 10.1007/s002040050010.
27. Badal S., Her Y. F., Maher L. J. Nonantibiotic effects of fluoroquinolones in mammalian cells. J Biol Chem. 2015; 290: 22287-97. doi: 10.1074/jbc.M115.671222.
28. Tam P. K., Ho C. T. Fluoroquinolone-induced Achilles tendinitis. Hong Kong Med J. 2014; 20: 545-547. doi: 10.12809/hkmj134105.
Review
For citations:
Kupriyanova I.N., Vedensky V.A., Valieva E.Ya., Sinitsina M.A. Damage to the musculoskeletal system during eradication therapy of Helicobacter pylori with levofloxacin. Experimental and Clinical Gastroenterology. 2021;(9):114-118. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-193-9-114-118
Views:
992
Email this article 